/PRNewswire/ The "Global Proteomics Partnering Terms and Agreements 2010 to 2023" report has been added to ResearchAndMarkets.com s offering. The Global.
/PRNewswire/ The "Flow Cytometry Services Market by Type of General Flow Cytometric Services, Type of Analysis based Flow Cytometric Services, Other types.
Published: May 18, 2021
IsoPlexis adds Switzerland as the latest country with access to their unique functional single-cell proteomics platform, adding to their existing partnerships across Asia and Europe.
BRANFORD, Conn., May 18, 2021 /PRNewswire/
IsoPlexis, the leader in single-cell proteomics, today announced an exclusive agreement with
Bucher Biotec AG, a Swiss distributor company representing some of the most advanced US, European, and Asian manufacturers of highly innovative life science research instrumentation, associated reagents, and consumables. This agreement follows IsoPlexis recent global distributor announcements, throughout Asia and Europe.
IsoPlexis IsoLight platform has received numerous awards, recognized as both The Scientist s and Fierce Life Science s #1 innovation for the ability to provide single-cell sensitivity with highly multiplexed and quantitative functional ELISA detection together for the first time. IsoPlexis IsoLight was awarded the
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Single-cell Sequencing Services and Technologies Market, 2020-2030 report features an extensive study of the current landscape and the future opportunities associated with single-cell sequencing services/technologies.
One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. Based on several parameters, such as number of single-cell samples sequenced annually, average cost of sequencing, and growth trends across various geographies, we have provided an informed estimate of the likely evolution of the market, in the mid to long term, for the period 2020-2030.